Doctor Patrick Foong

Doctor Patrick Foong

Academic Program Advisor,
School of Law

Senior Lecturer,
School of Law


I have taught law for many years in different countries and the last fifteen years, in the Australasian region. I have taught at undergraduate and postgraduate courses including LLB and LLM. I also supervise HDR students. I have extensive experience in designing curriculum, setting assessments and moderation. I have consistently achieved excellent teaching evaluation and I was rated as outstanding lecturer by Swinburne university students. I am familiar with the use of modern technologies such as Blackboard, Collaborate, Echo 360 and Audacity software.

Both of my postgraduate qualifications are by research and they are in critical areas at the time. My LLM thesis was on HIV/ AIDS and discrimination. In my PhD thesis, I conducted analysis and made comparisons between the Australian regulatory regime on human embryonic stem cell research and the Malaysian regime against the backdrop of the regulatory theories of Professor Roger Brownsword (Kings College London, UK) and Professor John Braithwaite (Australian National University). I publish in leading peer-reviewed journals, national (eg UNSW law journal and the Journal of Law & Medicine) and international (eg Asian Bioethics Review and Biotechnology Law Review). I am a regular contributor of opinion pieces to BioNews and BioEdge and I have also contributed to The Conversation (see 'Media'). In late 2021, I was a visiting scholar at the University of California, Los Angeles (UCLA) law school.

Currently, I am the academic program advisor for the law school. I was a member of the School’s Research and Higher Degree Committee for several years.

This information has been contributed by Doctor Foong.


  • PhD University of Tasmania

Professional Memberships

  • International Society for Stem Cell Research (ISSCR) (2012 - 2019)

Organisational Unit (School / Division)

  • School of Law
  • School of Law


Phone: (02) 9685 9217
Location: EK.G.40

PLEASE NOTE: obtaining information from this Directory must be for the legitimate purposes of doing business with and within Western Sydney University, and must not be used for unsolicited bulk e-mailing (spamming) or similar purposes.


Previous Teaching Areas

  • 200011 Contracts, 2020
  • 200295 Bioethics, 2019
  • 200813 Civil Procedure and Arbitration, 2019
  • 200957 Bioethics in Perspective, 2019


Journal Articles

  • Hashimi, M. and Foong, P. (2022), 'The drawing-up of laws on research involving human embryos in Australia : lack of an Islamic voice', Biotechnology Law Report, vol 41, no 1 , pp 30 - 38.
  • Foong, C. and Borsellino, G. (2022), 'Regulation of clinical trials and pandemic research : upholding ethical standards during a COVID-19 crisis', Biotechnology Law Report, vol 41, no 3 , pp 138 - 153.
  • Mangiapane, M. and Foong, P. (2022), 'How Australia's policymakers can ethically approach human germline genome editing technology', Journal of Law and Medicine, vol 29, no 3 , pp 740 - 759.
  • Borsellino, G., Foong, C. and Allan, S. (2021), 'The regulation and governance of clinical trials : past and present considerations to ensure ethical treatment of human participants', Journal of Law and Medicine, vol 28 , pp 421 - 438.
  • McKenzie, A. and Foong, C. (2021), 'Crispr-Cas9: The need for law reform in Australia', Eubios Journal of Asian and International Bioethics, vol 31, no 7 , pp 366 - 369.
  • Foong, C. (2020), 'Regulating unproven stem cell interventions : how effective are the ISSCR guidelines?', Biotechnology Law Report, vol 39, no 3 , pp 196 - 203.
  • Foong, C. (2019), 'Regulating human genome editing in Australia : overdue legislative review', Biotechnology Law Report, vol 38, no 1 .
  • Foong, C. (2019), 'Ownership issues in autologous stem cell therapies', Eubios Journal of Asian and International Bioethics, vol 29, no 6 , pp 186 - 191.
  • Foong, C. (2018), 'Stem cell tourism : addressing the challenge of regulatory cosmopolitanism', Eubios Journal of Asian and International Bioethics, vol 28, no 4 , pp 118 - 127.
  • Foong, C. (2018), 'Stemming the tide of unproven autologous stem cell therapies in Australia', University of New South Wales Law Journal Forum, .
  • Foong, C. (2017), 'Is human embryonic stem cell (HESC) research still necessary today?', Asian Bioethics Review, vol 9, no 1-2 , pp 33 - 44.
  • Foong, C. (2016), 'The regulatory regime for the use of embryos in research : Braithwaite's theory of responsive regulation', Eubios Journal of Asian and International Bioethics, vol 26, no 5 , pp 200 - 206.
  • Foong, C. (2016), 'Regulating human embryonic stem cell (HESC) research in Australia : Brownsword's regulatory challenges', Curtin Law and Taxation Review, vol 3 , pp 131 - 170.
  • Foong, C. (2014), 'Addressing exploitation of women in therapeutic cloning/somatic cell nuclear transfer (SCNT) research through strict legal oversight in Australia', Asian Bioethics Review, vol 6, no 4 , pp 359 - 370.
  • Foong, C. (2012), 'The need to pay egg donors for use in therapeutic cloning/Somatic Cell Nuclear Transfer (SCNT) research', Legal Issues in Business, vol 14 , pp 3 - 8.
  • Foong, C. (2012), 'The regulatory regime for human embryonic stem cell (HESC) research in Malaysia : a critique', Journal Undang-Udang dan Masyarakat: Malaysian Journal of Law and Society, vol 16 , pp 55 - 68.
  • Foong, C. (2011), 'Human embryonic stem cell (HESC) research in Malaysia : multi-faith perspectives', Asian Bioethics Review, vol 3, no 3 , pp 182 - 206.

My PhD topic was in the regulation of the controversial embryonic stem cell research. My current research interest is in the ethics and law of emerging biotechnologies eg organoid technology, human genome editing (eg CRISPR-Cas9), sheefs and others.  

I publish in leading international journals. I am a regular contributor to the Asian Bioethics Review (publication of the Centre for Biomedical Ethics at the National University of Singapore, a collaborating centre on bioethics of the World Health Organisation).

Each year, I present at the annual conference of International Society for Stem Cell Research (ISSCR), the largest stem cell organisation in the world as well as other conferences (national and international) and other conferences.

I have also contributed to The Conversation and they have been captured by the media (see 'Media'). My research should be useful to scientists, doctors, patients and their advocates/ carers, regulators, policy-makers, researchers and all concerned citizens, national as well as international.  

I am a member of the School of Law’s Research and Higher Degree Committee.

This information has been contributed by Doctor Foong.


Title: BioNews
Description: Concern over court ruling against the FDA regulating cell and gene therapies
Title: BioEdge
Description: Washington state prosecutes ???snake oil??? stem cell clinic
Title: BioNews
Description: Stem Cell Clinic to pay out Class Action Settlement
Title: BioEdge
Description: Class action over unproven stem cell treatment settled for US$3.65 million
Title: BioEdge
Description: Are human challenge studies for Covid ethical?
Title: BioEdge
Description: The CRISPR Babies: The Story Unfolds
Title: BioNews
Description: Unproven stem cell treatment industry in the USA: a concerning boom
Title: BioEdge
Description: Shonky stem cell products explode in US
Title: BioNews
Description: The Emergence of iBlastoids: Time to update the Law?
Title: BioEdge
Description: What is the law on iBlastoids?
Title: Cosmos
Description: Is it ethical to make human blastocysts in a lab?
Title: BioEdge
Description: A class action suit against an Australian IVF provider is a reminder that IVF is a huge industry
Title: BioNews
Description: Class Action Lawsuit: Has Monash IVF breached its Legal Duty of Care?
Title: BioNews
Description: California's Proposition 14: A Short in the Arm for Stem Cell Research
Title: BioEdge
Description: The California Institute for Regenerative Medicine gets a Second Lease of Life
Title: BioNews
Description: New Study on CRISPR: The Stake of Unintended Consequences in Embryos
Title: BioNews
Description: Patients with Neurological Diseases seeking Stem Cell Treatments
Title: BioEdge
Description: Regenerative Clinics: Strong Language from FDA
Title: BioEdge
Description: Covid-19: Should We Deliberately Infect Volunteers?
Title: BioNews
Description: Unproven Stem Cell Therapies, and now, Strong Words from FDA
Title: BioNews
Description: Stem Cells Touted for Coronavirus Treatments
Title: BioEdge
Description: Unscrupulous scammers are selling stem cell therapies for Covid-19
Title: BioEdge
Description: Ethical Issues Surrounding Egg Donation in Genome Editing
Title: BioNews
Description: Human-Animal Chimeras
Title: BioNews
Description: Human Genome Editing: What about the Protection of Egg Donors in Research?
Title: BioEdge
Description: How should chimeric embryo research be regulated?
Title: BioNews
Description: Designing Your Own Child
Title: BenchTV
Description: Stemming The Tide of Unproven Autologous Stem Cell Therapies in Australia
Title: BioEdge
Description: The brave new world of human genome editing: an Australian perspective
Title: BioEdge
Description: Fertility tourism: Australians travelling to US to have ???designer babies???
Title: BioEdge
Description: Right to try bills passed in US: more harm than good?
Title: BioEdge
Description: Untested stem cell therapies finally drawing attention of Australian regulators
Title: BioNews
Description: Confronting unproven stem cell treatments in Australia: the new regulation
Title: Unitas
Description: The Hwang Dilemma: Exploitation of Women in SCNT, 2009
Title: The Healthy Mummy
Description: Should We Rethink our Position on Embryo Research? 2017
Title: The Conversation
Description: What Australia needs to do to protect consumers from untested stem-cell treatments August 9, 2016
Title: The Conversation
Description: Destroying research embryos within 14 days limits chance of medical breakthroughs

Western Sydney University

Locked Bag 1797
Penrith NSW 2751

Tel: +61 2 9852 5222

ABN 53 014 069 881
CRICOS Provider No: 00917k